Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate/Severe Asthma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00411567
What this trial is testing

Assess the Efficacy of Inhaled Corticosteroid (ICS) Therapy in Moderate-Severe Bronchial Asthma

Who this might be right for
Bronchial Asthma
Novartis 26
Not applicableNot Yet RecruitingNCT07421115
What this trial is testing

Multicomponent Breathlessness and Physical Activity Intervention in People With Asthma Using a Digital Platform

Who this might be right for
Asthma (Diagnosis)Breathlessness
University of Newcastle, Australia 300
Large-scale testing (Phase 3)Study completedNCT03620747
What this trial is testing

Continuation of TRAVERSE- LTS12551 Evaluating Dupilumab Safety in Patients With Asthma (Long-Term Follow-Up)

Who this might be right for
Asthma
Sanofi 393
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07191535
What this trial is testing

Effect of Linvemastat in Patients With Partially Controlled Asthma (syMMPonia)

Who this might be right for
Asthma (Diagnosis)Pulmonary FunctionModerate-to-Severe Asthma
Foresee Pharmaceuticals Co., Ltd. 135
Early research (Phase 1)Study completedNCT01266941
What this trial is testing

Assess the Effects of Fluticasone Furoate and GW642444M Combination in Healthy Subjects and in Subjects With Mild, Moderate or Severe Hepatic Impairment.

Who this might be right for
Asthma
GlaxoSmithKline 35
Not applicableStudy completedNCT02153346
What this trial is testing

Indirect Cost of Illness Study of Moderate and Severe Asthma in Quebec

Who this might be right for
Asthma
GlaxoSmithKline 101
Testing effectiveness (Phase 2)Active Not RecruitingNCT07120503
What this trial is testing

Study to Evaluate the Safety, Pharmacology and Efficacy of WIN378 in Adults With Moderate or Severe Asthma

Who this might be right for
Asthma (Diagnosis)
Windward Bio 136
Testing effectiveness (Phase 2)Study completedNCT00330070
What this trial is testing

Control of Asthma Patients Symptomatic on Inhaled Corticosteroids

Who this might be right for
Asthma
Inflazyme Pharmaceuticals Ltd 200
Large-scale testing (Phase 3)Study completedNCT01202903
What this trial is testing

Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy

Who this might be right for
Persistent Allergic Asthma
Novartis Pharmaceuticals 616
Testing effectiveness (Phase 2)Study completedNCT00873860
What this trial is testing

Study to Evaluate the Safety and Efficacy of CAT-354

Who this might be right for
Asthma
MedImmune LLC 357
Large-scale testing (Phase 3)Study completedNCT00476073
What this trial is testing

Efficacy and Safety of Flutiform® pMDI in Adult Patients With Mild to Moderate-severe Reversible Asthma

Who this might be right for
Asthma Bronchiale
Mundipharma Research Limited 228
Large-scale testing (Phase 3)Study completedNCT05280418
What this trial is testing

Tezepelumab on Airway Structure and Function in Patients With Uncontrolled Moderate-to-severe Asthma

Who this might be right for
Asthma
McMaster University 27
Large-scale testing (Phase 3)Study completedNCT00219323
What this trial is testing

Long-Term Study of IGE025 in Moderate to Severe Bronchial Asthma.

Who this might be right for
Asthma
Novartis 133
Large-scale testing (Phase 3)Study completedNCT00079937
What this trial is testing

Efficacy and Safety of Omalizumab in Children (6 - < 12 Years) With Moderate-severe, Inadequately Controlled Allergic Asthma

Who this might be right for
Asthma
Novartis Pharmaceuticals 628
Not applicableStudy completedNCT06422663
What this trial is testing

Evaluate The Treatment Pattern Of Moderate-to-Severe Asthma Patients In China

Who this might be right for
Moderate-to-Severe Asthma
AstraZeneca 500
Large-scale testing (Phase 3)Study completedNCT06920771
What this trial is testing

A Randomized, Double-Blind, Placebo-Controlled, Multi-Centre Study to Assess the Efficacy of PURETHAL Mites Mixture 50,000 AUeq/mL Subcutaneous Immunotherapy in Adult Subjects With Moderate to Severe Allergic Rhinitis/Rhinoconjunctivitis With or Without Asthma Induced by House Dust Mite (HDM)

Who this might be right for
House Dust Mite AllergyHouse Dust Mite Rhinitis
HAL Allergy 691
Not applicableStudy completedNCT01823926
What this trial is testing

Asthma and Quantifying Delivery Of Radio Labeled Aerosol

Who this might be right for
Asthma
Universidade Federal de Pernambuco 13
Large-scale testing (Phase 3)Study completedNCT00419952
What this trial is testing

A Comparison of SYMBICORT® pMDI With Budesonide HFA pMDI in African American Subjects With Asthma.

Who this might be right for
Asthma
AstraZeneca 742
Large-scale testing (Phase 3)Study completedNCT03158311
What this trial is testing

Study to Compare QVM149 and Free Triple Combination of Salmeterol/Fluticasone + Tiotropium

Who this might be right for
Asthma
Novartis Pharmaceuticals 1,426
Testing effectiveness (Phase 2)Ended earlyNCT03393806
What this trial is testing

Repeat Dose Study of GSK3772847 in Participants With Moderate to Severe Asthma With Allergic Fungal Airway Disease (AFAD)

Who this might be right for
Asthma
GlaxoSmithKline 17
Next Page